X

Vous n'êtes pas connecté

Maroc Maroc - NEWS.MEDICAL.NET - A la Une - 23/Oct 02:57

Advancements in antibody-drug conjugates transform cancer therapy

Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy that combines the precision of monoclonal antibodies with the potency of cytotoxic drugs.

Articles similaires

Monoclonal antibodies: From magic bullet to precision weapon

oncologynews.com.au - 16:57

Monoclonal antibodies (mAbs) prevent, detect, and treat a broad spectrum of non-communicable and infectious diseases. Over the past few years, the...

Monoclonal Antibodies: Revolutionizing Drug Therapies

medindia.net - 17/Oct 09:23

Explore how mAbs are transforming disease treatment, the evolution from murine to humanized antibodies, and the impact of biosimilar antibodies on...

Monoclonal Antibodies: Revolutionizing Drug Therapies

medindia.net - 17/Oct 09:26

Monoclonal antibodies (mAbs) are special proteins used to help prevent, detect, and treat a wide range of diseases, both infectious and...

Nanoparticle Treatment: A Breakthrough Hope for Prostate Cancer Care

medindia.net - 18/Oct 23:00

A groundbreaking study has revealed a promising new approach to prostate cancer treatment. The nanoparticle-based therapy, guided by laser...

Precision Oncology: Role of MeCo Score in Personalized Breast Cancer Therapy

medindia.net - 24/Oct 16:38

Tissue stiffness in HER2-negative breast cancer, the most common type, can directly contribute to disease progression and metastasis, which can have...

Use of Mini-Proteins in Targeted Cancer Therapy

medindia.net - 26/Oct 05:03

Discover how mini-proteins deliver targeted radiation to Nectin-4 expressing tumor cells, sparing healthy tissues and offering new hope for cancer...

New Chemotherapy Regimen Boosts Cervical Cancer Survival by 40%

greekreporter.com - 21/Oct 17:05

A new study has revealed that a short course of chemotherapy before radiation therapy can significantly improve survival rates for cervical cancer...

Sorry! Image not available at this time

HKPR District Health Unit – Situational Assessment Report on the Drug Poisoning Crisis Now Available

todaysnorthumberland.ca - 23:07

Report promotes a collaborative four pillar approach to address community safety interventions. In partnership with the HKLN Drug Strategy, the...

Significant worldwide disparities in availability and timeliness of new cancer drugs

oncologynews.com.au - 18/Oct 16:58

Despite considerable progress in the discovery and development of new cancer drugs, there are significant disparities in both the availability and...

Sorry! Image not available at this time

Merck’s Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus (RSV) Preventative Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and Hospitalization in Healthy Preterm and Full-term Infants

drugs.com - 17/Oct 03:10

RAHWAY, N.J., Oct. 17, 2024 – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the presentation of...

Les derniers communiqués

  • Aucun élément